The lawsuit, filed on 17 January 2025, contends that PepsiCo's preferential treatment of a retailer constituted a breach of the Robinson-Patman Act (RPA), a legislation designed to protect fair competition by prohibiting anticompetitive price discrimination.
A lawsuit filed by the Federal Trade Commission alleges that food and beverage maker PepsiCo engaged in illegal price discrimination by giving unfair price advantages to one big-box retailer.
Insiders believing Walmart is Pepsi’s “likely” alleged beneficiary, according to NPR. The retail chain declined to comment. The FTC contends that “for years” the world’s second-largest ...
The Federal Trade Commission sued PepsiCo on Friday for offering preferential pricing to a large retailer, whom a source familiar with the matter confirmed was Walmart. The practices fed high ...
FTC accuses PepsiCo of illegal price discrimination, benefiting Walmart. Read about the lawsuit, PepsiCo’s response, and what it means for fair competition.
The FTC, whose legal filing was sealed, said PepsiCo provided promotional pricing deals to a single “big-box” customer. Walmart was the recipient of those incentives, according to people ...
When Andrew N. Ferguson took the helm last week at the FTC, his first act wasn't to announce new ways to crack down on corporate practices thought to be unfairly driving up consumer prices, it was to attack federal diversity and inclusion efforts as a "scourge.
PepsiCo, Inc. (NASDAQ:PEP), a global leader in the food and beverage industry with a market capitalization of $208.7 billion, is navigating a challenging market environment as it seeks to maintain its competitive edge and drive growth.
FTC Chair Lina Khan stated that allowing such a merger would have created “a market that is less competitive and more susceptible to price manipulation.” Consumer advocacy groups had also argued that smaller suppliers and independent grocers would struggle to compete with a retail behemoth, potentially forcing local stores out of business.
In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus. Lantus cost $292 for a 30-day supply. Drugmaker Viatris launched two
Amazon's e-commerce dominance, bolstered by AI personalization, in my opinion, ensures continued top-line growth and stock outperformance against the S&P 500. Read more here.
The pitch was so convincing that it made history on Shark Tank, bringing all five Sharks – Cuban, Kevin O'Leary, Daymond John, Lori Greiner and Robert Herjavec – together to invest a combined $1 million for a 30% stake,